UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
T&R Biofab’s 3D-printing medical device gets sales nod in Vietnam
T&R Biofab said Thursday that it has obtained sales approval from the Vietn...
by Lee Han-soo
|
2019-01-31 12:46
라인
Ipsen’s renal cancer drug Carbometyx gets insurance benefit
Ipsen Korea’s advanced renal cell carcinoma treatment Carbometyx (cabozanti...
by Park Gi-taek
|
2019-01-31 11:13
라인
Celltrion to export biosimilars to Latin America
Celltrion Healthcare said Thursday that it has successfully won bids to sup...
by Lee Han-soo
|
2019-01-31 11:12
라인
Samsung Bioepis’ biosimilar sales in EU exceed $500 million
Samsung Bioepis’ biosimilar sales in European Union surpassed $500 million ...
by Lee Han-soo
|
2019-01-30 18:17
라인
JVM posts ₩30.7 billion in Q4 sales
JVM, a subsidiary of Hanmi Pharmaceutical, said Tuesday that it recorded 30...
by Lee Han-soo
|
2019-01-30 17:19
라인
₩4.7 billion spent on compensation for side effect injuries in 4 years
Korea used 4.74 billion won ($4.24 million) to compensate the damages such ...
by Lee Hye-seon
|
2019-01-30 17:18
라인
‘Epilepsy patients can maintain normal memory functions after brain surgery’
Researchers at Seoul National University Hospital have discovered that neur...
by Lee Han-soo
|
2019-01-30 15:56
라인
Korea to expand hospitals to support patients with rare diseases
Korea will increase the number of regional hospitals providing care for rar...
by Kwak Sung-sun
|
2019-01-30 15:32
라인
Pfizer’s lung cancer drug Xalkori threatened by new rivals
Pfizer’s Xalkori (ingredient: crizotinib) has been solidifying its status a...
by Kim Yun-mi
|
2019-01-30 12:34
라인
Philips, Lunit, Vuno to cooperate on healthcare AI development
Philips said Wednesday that it has agreed with Lunit and Vuno to conduct R&...
by Lee Han-soo
|
2019-01-30 11:43
라인
Biogen, NHIS begin price talk for spinal muscular atrophy treatment
The National Health Insurance Service (NHIS) and Biogen started price negot...
by Lee Han-soo
|
2019-01-30 11:43
라인
Seoul goes all out to promote Korean healthcare in Middle East
Minister of Health and Welfare Park Neung-hoo returned from his three-day t...
by Lee Han-soo
|
2019-01-29 18:56
라인
Vatech posts record-high sales in 2018
Vatech said Monday it marked record sales and operating profit for the seco...
by Lee Han-soo
|
2019-01-29 16:48
라인
‘Network medicine contributes to customized treatment’
People are living in many networks. They make friends and communicate them ...
by Kim Do-jun
|
2019-01-29 16:46
라인
GC to stop making 1st thrombolytic agent amid poor sales
GC will stop manufacturing Urokinase, Korea’s first thrombolytic agent, aft...
by Lee Han-soo
|
2019-01-29 16:44
라인
Med school in hot seat for leniency with spy camera shooter
A male medical student, who recorded a showering scene of a female student ...
by Lee Min-ju
|
2019-01-29 16:43
라인
Ministry OKs Shire’s personalized device for hemophilia patients
Shire Korea said Monday that the Ministry of Food and Drug Safety has appro...
by Lee Han-soo
|
2019-01-29 12:51
라인
Vuno wins European certification for AI-based medical device
Vuno said Monday that it became the first local firm to receive Conformite ...
by Lee Han-soo
|
2019-01-29 12:51
라인
Government to tighten rule for drug license renewal
The government will not allow renewal of drug approval if a company manufac...
by Lee Hye-seon
|
2019-01-29 12:51
라인
Vuno, Hyewon Foundation to develop AI-based cardiovascular disease diagnosis technology
Vuno said Monday that it has agreed with Hyewon Foundation, which runs Sejo...
by Lee Han-soo
|
2019-01-28 18:04
-
이전
151
152
153
154
155
156
157
158
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top